Combined [18F]Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography (FDG-PET/CT) for Detection of Recurrent, 131I-Negative Thyroid Cancer
- 20 September 2007
- journal article
- Published by Springer Science and Business Media LLC in Annals of Surgical Oncology
- Vol. 15 (1), 286-292
- https://doi.org/10.1245/s10434-007-9611-5
Abstract
Whole-body 131I scintigraphy (WBS) and serial thyroglobulin measurement (Tg) are standard methods for detecting thyroid cancer recurrence after total/near total thyroidectomy and 131I ablation. Some patients develop elevated Tg (Tg-positive) or there is clinical suspicion of recurrence, but WBS are negative (WBS-negative). This may reflect non-iodine-avid recurrence or metastasis. In 2002, the Centers for Medicare and Medicaid Services (CMS) approved positron emission tomography with [18F]fluorodeoxyglucose (FDG-PET) for Tg-positive/WBS-negative patients with follicular-cell-origin thyroid cancer. Limited data are available regarding the performance of combined FDG-PET/computed tomography (FDG-PET/CT) for detecting recurrent thyroid cancer in WBS-neg patients. This retrospective review of prospectively collected data analyzed 65 patients who had FDG-PET/CT for suspected thyroid cancer recurrence (April 1998–August 2006). Patients were WBS-negative but were suspected to have recurrence based on Tg levels or clinical grounds. Suspected FDG-PET/CT abnormalities were reported as benign or malignant. Lesions were ultimately declared benign or malignant by surgical pathology or clinical outcome (disease progression). Of 65 patients who underwent FDG-PET/CT, 47 had positive FDG-PET/CT. Of the positive FDG-PET/CT, 43 studies were true positives, with 21 (49%) confirmed pathologically by surgical resection. The four false positives (3/4 confirmed pathologically) included an infundibular cyst, an inflamed supraclavicular cyst, pneumonitis, and degenerative disc disease. Of the 18 FDG-PET/CT studies that were negative, 17 were true negatives and one was a false negative (metastatic papillary carcinoma). Thus, FDG-PET/CT demonstrated a patient-based sensitivity of 98%, specificity of 81%, positive predictive value of 91%, and negative predictive value of 94%. FDG-PET/CT is useful for detecting thyroid cancer recurrence in WBS-negative patients, and can assist decision making.Keywords
This publication has 23 references indexed in Scilit:
- The role of PET in follow-up of patients treated for differentiated epithelial thyroid cancersNature Clinical Practice Endocrinology & Metabolism, 2007
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- Outcome of Differentiated Thyroid Cancer with Detectable Serum Tg and Negative Diagnostic 131I Whole Body Scan: Comparison of Patients Treated with High 131I Activities Versus Untreated PatientsJournal of Clinical Endocrinology & Metabolism, 2001
- Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicentre studyEuropean Journal of Nuclear Medicine and Molecular Imaging, 1999
- Imaging of Locally Recurrent and Metastatic Thyroid Cancer with Positron Emission TomographyThyroid®, 1999
- [18F]-2-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography Localizes Residual Thyroid Cancer in Patients with Negative Diagnostic 131I Whole Body Scans and Elevated Serum Thyroglobulin LevelsJournal of Clinical Endocrinology & Metabolism, 1999
- Surveillance of patients to detect recurrent thyroid carcinomaCancer, 1999
- Fluorine-18 fluorodeoxyglucose positron emission tomography and iodine-131 whole-body scintigraphy in the follow-up of differentiated thyroid cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 1997
- A Comparison of Serum Thyroglobulin Measurements and Whole Body 131l Scanning in the Management of Treated Differentiated Thyroid CarcinomaAustralian and New Zealand Journal of Medicine, 1982
- The comparative value of serum thyroglobulin measurements and iodine 131 total body scans in the follow-up study of patients with treated differentiated thyroid cancerAmerican Journal Of Medicine, 1981